Stock Market Christmas Eve 🎄
Up Next
8 videosU.S. takes over Cuba: which stocks rally?
January 16th, 2026
Elon Musk Broke His Own Rule to Defend His Divorce 💔🛠️
April 13th, 2025
If You Invested $10 in TRUMP Coin, Here’s What You’d Have Now
January 29th, 2025
Steve Jobs on Thinkers And Doers
October 19th, 2024
Tesla owner's struggles during the winter
October 2nd, 2024
Chinese Man Disqualified From Marathon For Chain-Smoking Cigarettes During The Race
January 30th, 2024
Comedians Playing Basketball
December 19th, 2023
Why Hollywood Is Dying
February 20th, 2026
US stock futures are slightly lower this Wednesday morning, but several individual stocks are making sharp moves on index changes, FDA approvals, earnings, and corporate actions. Here are the stocks investors are watching today: UiPath (PATH) Surged after S&P Dow Jones Indices announced UiPath will join the S&P MidCap 400, replacing Synovus Financial, effective January 2, 2026. Shares jumped 6.8 percent to $17.05 in after-hours trading. Agios Pharmaceuticals (AGIO) Announced FDA approval of Mitapivat (EcVSmi) to treat anemia in adults with alpha or beta thalassemia. Despite the approval, shares slipped 1.4 percent to $24.59. Fight BioPharma (FIGHT) Announced a 1-for-3000 reverse stock split, sending shares down 28.8 percent to $0.17 after hours. Cush Pharmaceuticals (CUSH) Delivered better-than-expected Q4 results, posting a $0.11 loss per share versus estimates of a $0.43 loss. Shares surged 22.1 percent to $1.27 after hours. Ramaco Resources (METC) Jumped 7.1 percent to $18.09 after announcing a $100 million share buyback program. 📈 Follow Benzinga for fast market updates, earnings recaps, and breaking stock news. #PATH #FIGHT #Stockmarket 🖥️ Try Benzinga Pro FREE with a 14 day trial: https://www.benzinga.com/pro/register 📈 Take your trading to the next level with our suite of premium research services and tools: https://www.benzinga.com/services 🌐 Find more market-moving insights at https://www.benzinga.com — your one-stop destination for the latest financial news, data, and expert analysis to stay ahead of the markets. 📲 Follow us on socials @benzinga ------------------------------------------------------------------------------------ 🔹Free Benzinga Webinars: https://www.youtube.com/watch?v=LQ2jOJNkDfI&list=PL4k0fH8EgI3YTdqniRmxrvz97w3IQ61rD 🔹Benzinga Pro Tutorials: https://www.youtube.com/watch?v=a2FaHhLIrks&list=PL4k0fH8EgI3YMwoBMFXGvVMkgixFymmei&pp=gAQB 🔹Earnings Calls: https://www.youtube.com/watch?v=C2-AoCw64Ok&list=PL4k0fH8EgI3buZI5529R53wJUNd9NS4_s 🔹Premarket Playbook: https://www.youtube.com/playlist?list=PL4k0fH8EgI3ZVRPM7INpG--GvohnBVTnT 🔹Benzinga's All Access: https://www.youtube.com/playlist?list=PL4k0fH8EgI3bQSn91atO-3lPT4V6Nwsmh 🔹Subscribe To The Channel: https://www.youtube.com/@Benzinga ------------------------------------------------------------------------------------ ⚠️ Disclaimer: Investing in financial markets carries risk, and there are no guaranteed returns. All information is for educational purposes only and should not be taken as financial advice. Always do your own research and speak with a qualified financial advisor before making investment decisions. Only invest what you can afford to lose. Past performance does not guarantee future outcomes. #StockMarketNews #Trading #StockMarketLive #Stocks #stocktrading #learntotrade #DayTrading #StockMarketToday
